Centrum 7/6  banner

January 9, 2023

You can read the full January 9th print issue of Chain Drug Review in its entirety here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!

Standley honored for life’s work in retail industry

Standley honored for life’s work in retail industry

NEW YORK — John Standley’s road was long and winding, but the direction was always upward. Early lack of ambition — his father applied to college for him — did not prevent Standley from ascending to the very heights of chain drug retailing, first as chief executive officer of Rite Aid, and then as president

Fruth named Regional Drug Chain of the Year

Fruth named Regional Drug Chain of the Year

POINT PLEASANT, W.Va. — Fruth Pharmacy has been making its mark in the industry over the past 70 years by sticking to old-fashioned values and the motto “to do the right thing” as it continues to help take care of its patients and customers. Lynne Fruth, the chain’s president, says the West Virginia-based company’s long-term

Heath Care Outlook 2023: Lee Ann Stember, NCPDP

Heath Care Outlook 2023: Lee Ann Stember, NCPDP

Change is inevitable. This is a particularly exciting time to be in pharmacy, as we witnessed pharmacists’ swift support on the front lines of the COVID-19 pandemic, further demonstrating the need for and value of pharmacist-provided patient care services, pharmacists’ value to their communities, and a future for the expanded role of pharmacists. The pharmacy

Health Care Outlook 2023: Sandra Hanna, Neighbourhood Pharmacies

Health Care Outlook 2023: Sandra Hanna, Neighbourhood Pharmacies

A key takeaway for our federal and provincial governments in Canada throughout the pandemic was that no matter how daunting, community pharmacy rose to the challenge and delivered. From triage to testing, education to vaccination, our capability to serve as community health hubs, touted before the pandemic, was validated. Our governments are finally realizing that

Health Care Outlook 2023: Sheila Arquette, NASP

Health Care Outlook 2023: Sheila Arquette, NASP

Specialty pharmacy continues to be dynamic, demanding and disruptive, undergoing rapid and dramatic change. Specialty pharmacies connect patients diagnosed with life-altering and often life-threatening complex health conditions, including cancer, rheumatoid arthritis, multiple sclerosis, cystic fibrosis, hemophilia, rare and orphan diseases, and organ transplantation, with the medications prescribed for their conditions. The expert services that specialty

Rauch wins top merchant award

Rauch wins top merchant award

DEERFIELD, Ill. — Walgreens’ overarching strategy is built on a combination of health and wellness expertise and exceptional convenience, says senior vice president and chief merchandising officer Luke Rauch. Together, those elements give the company “the unique right to win,” says Rauch, who has been in his current role since the spring. In recognition of

Health Care Outlook 2023: Scott Melville, CHPA

Health Care Outlook 2023: Scott Melville, CHPA

Last year I reported that the COVID-19 pandemic drove tremendous growth in demand for over-the-counter medicines for pain and fever, dietary supplements for immune support and wellness, and consumer medical devices for self-diagnosis and protection. Now as we welcome 2023, not only has this demand continued, it has accelerated. The drivers of growth and innovation

Branded Drug Report 2023: Lisa Joldersma, PhRMA

Branded Drug Report 2023: Lisa Joldersma, PhRMA

In recent decades, pharmacy benefit managers have grown into shadowy and hugely influential players in the prescription drug supply chain. For the most part, they have managed to avoid public scrutiny and government regulation. Fortunately, that’s starting to change, as policy makers find it difficult to overlook rampant conflicts of interest at the core of

Health Care Outlook 2023: Peter Matz, FMI

Health Care Outlook 2023: Peter Matz, FMI

As the COVID-19 pandemic enters its third year, the public health emergency (PHE) declaration that has underpinned the country’s COVID-19 response efforts by providing the federal government with emergency powers, regulatory flexibilities and additional resources is currently set to expire in early 2023. However, the Biden administration has pledged to give 60 days’ notice before

Health Care Outlook 2023: Ilisa Bernstein, APhA

Health Care Outlook 2023: Ilisa Bernstein, APhA

The pharmacy profession and patient care services delivered by the pharmacy team have evolved significantly over the past few years, bringing new opportunities and challenges. The pandemic has spotlighted the value of pharmacies as vital access points to care, leading policy makers and payers to explore new ways to engage pharmacists and the pharmacy team.

Branded Drug Report 2023: John O’Brien, NPC

Branded Drug Report 2023: John O’Brien, NPC

A contentious midterm election is behind us, and while pundits and other experts argue about what the results mean, those of us who deeply care about sound health care policy can hope for a new year where solid evidence and the quest for transparent information matters at least as much as political rhetoric. We’ve come

Health Care Outlook 2023: B. Douglas Hoey, NCPA

Health Care Outlook 2023: B. Douglas Hoey, NCPA

New, exciting trends are emerging in community pharmacy practice, but what’s past is still prologue. Sal D’Angelo, a past president of the National Community Pharmacists Association/National Association of Retail Druggists, was the first person I heard say, “Get into politics or get out of pharmacy.” Sal spoke those words a long time ago, and he

PP_1170x120_10-25-21